Lee Fidler
@twhcmr
Followers
396
Following
1K
Media
2
Statuses
664
Father, Respirologist, ILD doc, guitar collector, weekend runner
Joined July 2013
Congratulations @UofTRespirology @shapps999 on a fantastic educational day on #ILD. 🫁⚕️🩻 📊 I am thrilled to be speaking alongside @jolenehfisher @leefider #DrMeyerBalter. So much to learn from interdisciplinary discussions. 🧐🤔🙂
1
1
16
@jolenehfisher, @twhcmr and I were honored to have @drdayjee at our @UofTRespirology #ILD educational day. He gave a fantastic talk on genetics of ILD and biomarkers: past, present and future. Thanks @drdayjee for coming along the way to Toronto to enhance our event! 🙏🙏🙏
0
1
7
A thread of 20 Survival Tips And Tricks You Might Not Have Known Before. 1. How to break a door
349
7K
75K
Dr. Nick Daneman presents the much-awaited BALANCE trial presented at #IDWeek2024. Of 3608 randomized, 90-day mortality occurred in 261 (14.5%) patients receiving 7-day and in 286 (16.1%) receiving 14-day treatment (absolute difference -1.6% [95.7% CI -4.0 to 0.8])
1
43
132
Our review paper led by Alene Saavedra, outlining several nuances that emerged for RA-ILD treatment in the recent ACR/CHEST guideline - in particular AZA and MMF We also review all trial evidence - only 3 RCTs (n=217 total!) have enrolled RA-ILD pts! https://t.co/giRbviAzM1
link.springer.com
Current Treatment Options in Rheumatology - To summarize the current treatment landscape of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) in the context of the recent 2023...
2
21
56
Efficacy and Safety of Admilparant, an LPA1 Antagonist in #PulmonaryFibrosis: A Phase 2 Randomized Clinical Trial A positive signal in a relatively large study cohort but with short 26 week duration. https://t.co/WZBBxZdMEX
0
3
4
ERJ Podcast: Titration of anti-IL-5 biologics in severe asthma ERJ Deputy Chief Editor @donsin4 & Marianne Baastrup Soendergaard discuss the OPTIMAL study: an open-label RCT of titration of anti-interleukin-5 biologic therapy in severe asthma: https://t.co/qzBQ6xxwxH
0
9
18
Positive phase 3 trial in IPF : awaited for the past 10 years. A major step forward in the field. Congratulations on behalf of the whole ILD community. Stay tuned for more information with the publication to come
#NEWS: We’re excited to announce that our Phase III trial in people living with idiopathic pulmonary fibrosis (IPF) met its primary endpoint. Learn more here: https://t.co/KmlQf4lvyM
0
20
72
🚨🚨#Rituximab + #Mycophenolate Mofetil (MMF) for Interstitial Lung Disease 🌬️ (EVER-ILD Trial) 💡 Objective: Evaluate if Rituximab+MMF improves lung function in patients with NSIP-ILD 🫁 📊 Key Findings: 🫁 FVC % predicted change: No significant improvement at 12 months ❌
2
48
146
Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-#ILD): one-year follow up results of a randomized controlled trial Addition of rituximab to MMF prolonged PFS. #NSIP #IPAF Ahead of #ERScongress
https://t.co/tkZXsatHaj
2
35
74
Brilliant educational algorithm on how to approach fever in neutropenia Source: Amboss
10
246
991
Happy to share that the proceedings of the 7th World Symposium on Pulmonary Hypertension are out. Here is our article on PH associated with chronic lung diseases
0
19
51
MTX and ILD🫁❓ 👉Study showing MTX treatment not associated with increased risk of RA-ILD. #APLAR2024 💡Many DMARDs are safe💊 Just jumped into RA and ILD session💨
3
21
48
12 genius anti-smoking ads I've collected: 1. Lung Pong
13
123
2K
Connect the 2 images ; A patient with chronic cough and difficulty with breathing with history of tobacco smoking. Diagnosis? What is the sign seen in this image? Findings on the radiograph? Treatment? #MedTwitter #Olympic2024 #MedEd #MedX #FOAMed #Medicine #CardioTwitter
11
51
290
Master time management:
113
9K
45K